1. Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2. Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3. Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Therapeutic Drug
Monitoring Market
5. Global Therapeutic Drug Monitoring Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Drug Class (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug,
Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, Others)
5.2.2.
By Technology (Immunoassay, Chemiluminescence Immunoassay, Colorimetric
Immunoassay, Fluorescence Immunoassay, Radioimmunoassay, Others)
5.2.3.
By Region
5.2.4.
By Company (2024)
5.3.
Market Map
6. North America Therapeutic Drug Monitoring
Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Drug Class
6.2.2.
By Technology
6.2.3.
By Country
6.3. North
America: Country Analysis
6.3.1. United
States Therapeutic Drug Monitoring Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Class
6.3.1.2.2.
By Technology
6.3.2. Mexico
Therapeutic Drug Monitoring Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Class
6.3.2.2.2.
By Technology
6.3.3. Canada
Therapeutic Drug Monitoring Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Class
6.3.3.2.2.
By Technology
7. Europe Therapeutic Drug Monitoring Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Drug Class
7.2.2.
By Technology
7.2.3.
By Country
7.3. Europe:
Country Analysis
7.3.1. France
Therapeutic Drug Monitoring Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Technology
7.3.2. Germany
Therapeutic Drug Monitoring Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Technology
7.3.3. United
Kingdom Therapeutic Drug Monitoring Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Technology
7.3.4. Italy
Therapeutic Drug Monitoring Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Class
7.3.4.2.2.
By Technology
7.3.5. Spain
Therapeutic Drug Monitoring Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Class
7.3.5.2.2.
By Technology
8. Asia Pacific Therapeutic Drug Monitoring
Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Drug Class
8.2.2.
By Technology
8.2.3.
By Country
8.3. Asia
Pacific: Country Analysis
8.3.1. China
Therapeutic Drug Monitoring Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Technology
8.3.2. India
Therapeutic Drug Monitoring Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Technology
8.3.3. South
Korea Therapeutic Drug Monitoring Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Technology
8.3.4. Japan
Therapeutic Drug Monitoring Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Technology
8.3.5. Australia
Therapeutic Drug Monitoring Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Technology
9. South America Therapeutic Drug Monitoring
Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Drug Class
9.2.2.
By Technology
9.2.3.
By Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Therapeutic Drug Monitoring Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Technology
9.3.2. Argentina
Therapeutic Drug Monitoring Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Technology
9.3.3. Colombia
Therapeutic Drug Monitoring Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Technology
10. Middle East and Africa Therapeutic Drug Monitoring
Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Drug Class
10.2.2.
By Technology
10.2.3.
By Country
10.3. MEA:
Country Analysis
10.3.1. South
Africa Therapeutic Drug Monitoring Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Technology
10.3.2. Saudi
Arabia Therapeutic Drug Monitoring Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Technology
10.3.3. UAE
Therapeutic Drug Monitoring Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Technology
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers
14. Global Therapeutic Drug Monitoring Market: SWOT
Analysis
15. Porters Five Forces Analysis
15.1.
Competition in the Industry
15.2.
Potential of New Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute Products
16. Competitive Landscape
16.1.
Roche AG
16.1.1.
Business Overview
16.1.2.
Company Snapshot
16.1.3.
Products & Services
16.1.4.
Financials (As Reported)
16.1.5.
Recent Developments
16.1.6.
Key Personnel Details
16.1.7.
SWOT Analysis
16.2.
Siemens Healthcare GmbH
16.3.
Thermo Fisher Scientific, Inc.
16.4.
Bio-Rad Laboratories, Inc.
16.5.
Beckman Coulter, Inc.
16.6.
Abbott Laboratories, Inc.
16.7.
Agilent Technologies, Inc.
16.8.
bioMérieux, Inc.
16.9.
Alere, Inc.
17. Strategic Recommendations
18. About Us & Disclaimer